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ABSTRACT
Human genome sequencing efforts have greatly ex-
panded, and a plethora of missense variants iden-
tified both in patients and in the general popula-
tion is now publicly accessible. Interpretation of the
molecular-level effect of missense variants, however,
remains challenging and requires a particular inves-
tigation of amino acid substitutions in the context
of protein structure and function. Answers to ques-
tions like ‘Is a variant perturbing a site involved in
key macromolecular interactions and/or cellular sig-
naling?’, or ‘Is a variant changing an amino acid lo-
cated at the protein core or part of a cluster of known
pathogenic mutations in 3D?’ are crucial. Motivated
by these needs, we developed MISCAST (missense
variant to protein structure analysis web suite; http:
//miscast.broadinstitute.org/). MISCAST is an inter-
active and user-friendly web server to visualize and
analyze missense variants in protein sequence and
structure space. Additionally, a comprehensive set of
protein structural and functional features have been
aggregated in MISCAST from multiple databases, and
displayed on structures alongside the variants to pro-
vide users with the biological context of the variant
location in an integrated platform. We further made
the annotated data and protein structures readily
downloadable from MISCAST to foster advanced of-
fline analysis of missense variants by a wide biolog-
ical community.
INTRODUCTION
Large-scale genome and exome sequencing projects have
identified millions of single amino acid-altering missense
variants in the relatively healthy general population (1).
In addition, the growing use of genetic screening in clini-
cal practice has revealed a large number of missense vari-
ants as the molecular basis of many diseases (2,3). With
the aim of persistent data sharing and subsequent analy-
sis, the variant level data are now systematically aggregated
in many public databases such as ExAC (Exome Aggre-
gation Consortium) (4), gnomAD (Genome Aggregation
Database) (5), ClinVar (6), HGMD (Human Gene Muta-
tion Database) (7) and OMIM (8). Concomitantly with the
growth of genomics data, rapid advances in electron mi-
croscopy and other experimental techniques for determin-
ing macromolecular structure have produced thousands of
protein structures that are accessible through resources like
RCSB PDB (9) and PDBe (10). These data now offer an
opportunity to study the molecular-level effect of missense
variants in the context of protein structure and function.
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Given that the damaging and/or neutral consequences
of missense variants are reportedly associated with the
structural properties of the affected amino acids (11,12),
studying these variants’ effect on protein structure rep-
resents a growing research area. However, linking single
nucleotide variations (SNVs) from VCF files to the lo-
cation of the amino acid substitution on the structure
(stored in PDB files, https://www.rcsb.org/) is still challeng-
ing. The formats of VCF and PDB files are largely differ-
ent and their integration requires a bioinformatic skillset, ad
hoc computing, and expertise in processing both genomics
and structural data. Nonetheless, resources and tools have
been developed to map missense variants on protein struc-
tures such as ASTRID (http://astrid.icompbio.net/), muta-
tion3D (13), COSMIC-3D (14), VarSite (15), VarMap (16),
PhyreRisk (17). While some of these tools provide the user
with still graphics of protein structures with pre-mapped
variants (e.g. ASTRID), some allow users to input variants
and view them on the structure (mutation3D, COSMIC-
3D, PhyreRisk, VarMap, etc.). Notably, some studies went
beyond the mapping of variants onto the experimentally-
solved structures only, and incorporated structure mod-
els and alternative transcripts to cover nearly the full pro-
teome (e.g. PhyreRisk, VarMap). However, an integrated vi-
sual analytic platform to display variants and biologically-
relevant features of residues on protein sequence and struc-
ture in a common web environment is not available. Re-
cently developed 3DBIONOTES-WS server (18) performs
concurrent sequence-structure visualization, which, how-
ever, does not allow to export the annotated data and 3D
structures, limiting the opportunity for downstream anal-
ysis. To address these challenges, we have developed MIS-
CAST:MIssense variant to protein StruCture Analysis web
SuiTe (http://miscast.broadinstitute.org/).
MISCAST is an interactive web server where protein se-
quences are pre-annotatedwith disease-associated and pop-
ulation variants alongside a rich collection of biological
context (structural, physicochemical and/or functional pro-
tein features), which are simultaneously overlaid on protein
structures. The purpose of MISCAST is to support the sci-
entific community in performing a quick, online inspection
of missense variants on protein structures as well as allow
users to download the structures annotated with variants
and features to perform advanced offline investigation in
PyMOL (https://pymol.org/2/).
MATERIALS AND METHODS
Collecting and filtering missense variants
Missense variants in the general population were re-
trieved from the gnomAD database, public release
2.1.1 (Figure 1A). Consolidated files for all available
exomes and genomes were downloaded as VCFs from
http://gnomad.broadinstitute.org/downloads. Missense
variants for canonical transcripts were extracted using the
vcftools (19) and filtered based on the gnomAD standard
quality control flag (‘PASS’). The disease-associated mis-
sense variants were collected from two databases: ClinVar
(October, 2019 release) andHGMD® (professional release
2018.4). ClinVar data were filtered to keep variants with
‘Pathogenic’ and/or ‘Likely-Pathogenic’ clinical conse-
quences. At the same time, the HGMD data were filtered
to keep the high confidence disease-associated variants
(confidence = ‘HIGH’, variantType = ‘DM’ or disease
mutation). All annotations refer to the human reference
genome version GRCh37.p13/hg19. Variants annotated to
non-canonical transcripts were not considered.
In this paper and on the MISCAST web server, the vari-
ants obtained from gnomAD database, and that from Clin-
Var and HGMD databases are referred to as ‘population’
and ‘pathogenic’ variants, respectively.
Collecting protein sequences, structures, functional-class an-
notations
All available experimentally-solved human 3D structures
(in full or chimeric) were collected from the PDB, repre-
senting proteins encoded by 5850 genes. We filtered out 943
genes for which the canonical protein isoform sequences
are not translated from the canonical transcripts. Out of
the remaining 4907 genes, pathogenic missense variants
were available for 1685 genes (ClinVar and/or HGMD
databases). We further filtered out 355 genes for which no
pathogenic variant was mappable onto the structures of
the encoded proteins. Finally, we obtained 1330 genes, har-
boring in total 406,449 population and 54 137 pathogenic
variants. For the vast majority of the genes (1322 out of
1330), the variants correspond to the Ensembl canonical
transcripts while the RefSeq transcripts were used for the
remaining genes. These variants are mapped onto 17 953
protein structures upon retrieving the residues’ positions on
the structure from the SIFTS database (20) (Figure 1A).We
then annotated the 1330 genes with encoded protein’s func-
tional class information, collected from the PANTHER (19)
database. The lists of genes, transcripts, and protein class
annotations are available at https://github.com/dlal-group/
MISCASTv1.0.
Collecting protein features
We collected amino acid-wise annotations of forty pro-
tein features (a combination of structural, physicochemi-
cal and functional features) grouped into seven main cate-
gories: (i) 3-class secondary structures; (ii) 8-class secondary
structures; (iii) residue exposure levels; (iv) physicochemi-
cal properties of amino acids; (v) protein-protein interac-
tions; (vi) post-translational modifications (PTMs) and (vii)
functional features. The secondary structure and solvent-
exposure of amino acids were calculated using the DSSP
program (22). Protein–protein interactions, PTMs, and
functional features were obtained from the PDBsum (23),
PhosphoSitePlus (24) and UniProt (25) databases, respec-
tively (Figure 1B). The detailed feature mining and ascer-
tainment procedure are described in the MISCAST (‘Doc-
umentation’) web server.
Implementation of MISCAST
MISCAST is developed as a fully browser-based web ap-
plication using the Shiny R package (https://shiny.rstudio.
com/) in RStudio development environment (Figure 1C).
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Figure 1. MISCAST architecture, main modules, and data flow. (A) Online resources used for collecting missense variants, gene symbols, protein sequences
and structures. (B) Databases searched to aggregate gene- and residue-wise biological context annotations. (C) MISCAST development using Shiny R
package and deployment using Google Cloud services. (D) Three main visualization schemes of MISCAST. Missense variants and protein features are
displayed in 1D, 2D and concurrent 1D </> 3D views.
Shiny can interactively translate queries from the user-end
into HTML code, perform data analysis and computa-
tion in the back-end, and can display the results on the
browser page in an extended fashion using CSS themes
and JavaScript widgets. The annotation tracks (missense
variants and protein features) per gene were assembled as
tab-delimited text files (available at https://github.com/dlal-
group/MISCASTv1.0). The summary reports on the ef-
fect of missense variants are dynamically generated by lan-
guage processing, embedded in the R code written forMIS-
CAST server. All the data and codes were uploaded as a
self-standing container with Google Cloud services, which
was then deployed into a Google Virtual Machine (VM).
MISCAST is compatible with all commonly used internet
browsers––with no installation or login requirement.
MISCAST leverages multiple JavaScript plugins to dis-
play missense variants and feature annotations on protein
sequences and structures as informative visuals (Figure 1
D). The multiple sequence alignment (MSA) viewer (26) is
used to visualize the protein sequence. All two-dimensional
plots are generated using the R libraries, ggplot2 (27) and
plotly (https://plot.ly). The concomitant visualization of an-
notations on sequence and structure was enabled by the
MolArt tool (28). For a given gene, MolArt retrieves the
available structure identifiers for the encoded protein us-
ing the Proteins API (29), obtains the sequence-structure
mapping from SIFTS (20), and then displays the annota-
tions on sequence and structure using ProtVista (30) and
LiteMol (31) plugins, respectively. All the annotation tracks
(pathogenic and population variants and forty protein fea-
tures) for sequence (amino acid wise, as tab-delimited text
file) and structure (as PyMOL file) are exportable. Further,
the graphical and textual results are readily downloadable
to use for scientific publication, presentation or downstream
analysis.
RESULTS AND CASE STUDY
MISCAST web server
MISCAST is an interactive web server for integrated visu-
alization of missense variants on the amino acid sequence
and 3D structure of proteins. The current version of MIS-
CAST includes all human geneswith at least one pathogenic
variant (ClinVar and HGMD databases) and those from
the general population (gnomAD database) mappable onto
an experimentally-solved 3D structure. Additionally, MIS-
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CAST includes residue-wise annotations of protein features
reporting on amino acids’ chemical properties (e.g. aro-
matic versus charged or polar), structural context (-helix,
- sheet, participation in hydrogen bonds, etc.) and their
role in protein function (i.e. involvement in an enzyme’s ac-
tive site, cellular signaling, etc.). These features are con-
comitantly viewable on protein sequences and structures
alongside the missense variants, allowing users to examine
the effect of variants considering the features of the affected
residue.
MISCAST also shows annotations of the genes with
protein-class information (kinases, transporters etc.) to pro-
vide the user with function-specific insights e.g. Is a variant
of a gene encoding for a kinase perturbing the catalytic 3D
site that is essential for the protein’s enzymatic activity? Fi-
nally, MISCAST highlights protein features that are associ-
ated with (or enriched for) pathogenic and population mis-
sense variants (32) in general (‘All protein classes’) and for
specific groups of genes (i.e. encoding for a protein class).
The homepage of MISCAST has two main navigation
tracks: (i) variant analysis suite: enables inspection and
analysis of variants upon querying by a gene symbol; (2)
variant summary report: provides a report and an index de-
scribing the effect of missense variants based on the prop-
erties of the altered amino acids. At any point in the explo-
ration, users can switch between the tracks from the ‘Select
Track’ drop-down menu in the top navigation panel (Fig-
ure 2A).
Variant analysis suite: information
Query by anHGNC gene symbol from the Variant Analysis
Suite opens up the ‘Information’ page for that gene showing
the UniProt accession (hyper-linked to UniProtKB), name
and length of the encoded protein, variant counts, and the
protein’s functional class information.
For example (Figure 2A), querying forDDX3Xwill show
that it encodes for a 662-residue long ATP-dependent RNA
helicase, which is a nucleic acid-binding protein. ClinVar
and HGMD databases jointly record 44 missense variants
ofDDX3X; however, due to the partial coverage of the pro-
tein in structure, 39 of those (about 89%) were mappable
on the structure. On the other hand, only about 50% (out
of 79) of all missense variants of DDX3X obtained from
gnomAD database were mappable on the protein structure.
Here, users will also find the protein features associatedwith
pathogenic and populationmissense variants in general (‘All
protein classes’) and specifically for the class whichDDX3X
is annotated with, i.e. nucleic acid-binding protein. For ex-
ample, the -helical residues are particularly enriched with
pathogenic variants of nucleic acid-binding proteins.
Variant Analysis Suite: 1D visualization
The purpose of the 1D visualization page is to display the
missense variants and functionally-relevant protein features
at the amino acid level. Triggered by the query by gene, the
page first shows the encoded protein sequence in the MSA
viewer (Figure 2 B). Using the gray navigation bar, users
can see the full sequence with residues colored according to
the presence of pathogenic (red), population (blue) or both
types (orange) of variants. This color scheme has been con-
sistently maintained in every page of MISCAST to indicate
the missense variant types. The sequence viewer is interac-
tive: Users can double-click on the amino acid, which will
in turn expand a panel below displaying the features of the
selected amino acid and details of the available pathogenic
(associated phenotype) and population (allele count and
frequency values) variants.
Continuing with the example of DDX3X (Figure 2B),
clicking on theArginine (Arg/R) at position 326 (R326) will
show that two different R326 mutations have been recorded
as pathogenic in ClinVar: p.Arg326His (R > H) is associ-
ated with mental retardation and intellectual disability and
p.Arg326Cys (R > C) is associated with inborn genetic dis-
eases. Relevant protein features of R326 are also displayed,
such as it forms an -helix, it is close (∼5 A˚) to a phos-
phorylation site in 3D despite being distant in sequence
(25 residues gap), and is located in a region interacting
with many other proteins (GSK3B, XPO1). These features
alongside the variant information can guide the user to gen-
erate an informed hypothesis on the impact of a particular
amino acid substitution.
Variant analysis suite: 2D visualization
The 2D visualization page per gene shows the distribution
of pathogenic and population missense variants’ positions
across the protein sequence along with the protein feature
information. The page is organized into seven subheadings
for seven main protein feature categories, displaying the 2D
plots of feature types (y-axis) of the amino acid residues (x-
axis). The locations of variants in the plot are highlighted in
colors by variant type. All the plots are readily download-
able. Hovering over the plots in the browser will display the
residue position and corresponding amino acid. For large
proteins or densely annotated regions, the user can zoom
in or expand a specific segment of the protein using the
‘box’/‘lasso’ select capability to improve visualization. At
any time, the axes can be reset using the ‘home’ icon in the
control bar. These plots enable the user to analyze the mis-
sense variants in the context of features of residues or re-
gions of functional interest.
For example, the distribution of DDX3X variants
mapped on to the sequence along with the residues’ sol-
vent accessible surface area (ASA) clearly illustrates that the
residues with low ASA (<25 A˚2) are frequently affected by
pathogenic variants, perturbing the compact protein core
which often leads to the destabilization of the structure
(Figure 2C). On the contrary, the population variants tend
to affect residues that are more exposed (>50 A˚2 ASA).
Variant analysis suite: 3D visualization
Concurrent display of missense variants on protein se-
quence and structure in a common environment is one of
the core capabilities of MISCAST, which is available per
gene in the 3D visualization page. As an added dimension,
all aggregated biologically relevant protein features are si-
multaneously overlaid on the structure (Figure 3). This al-
lows users to visually inspect the features of pathogenic and
population variant positions in the context of 3D structure.
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/article/48/W
1/W
132/5836773 by guest on 22 Septem
ber 2020
W136 Nucleic Acids Research, 2020, Vol. 48, Web Server issue
Figure 2. Selected visual and textual output of the Variant Analysis Suite track of MISCAST web server for the discussed case study. (A) Selection of a
gene (DDX3X) opens up the ‘Information page’, displaying general overview of the encoded protein. (B) 1D visualization page to explore amino acid-
wise missense variants alongside biologically-relevant protein feature annotations. (C) 2D visualization page to display missense variants in the context of
feature annotations for the full protein sequence.
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Figure 3. Illustration of MISCAST’s display of missense variants and protein feature annotations simultaneously on protein sequence (left panel) and
structure (right panel). Mapping for pathogenic and population variants on the structure of DDX3X encoded ATP-dependent RNA helicase, along with
highlighted (yellow) protein features annotation, shows a potential 3D mutational hotspot (cluster of pathogenic variants) in the C-terminal helicase
domain.
For example, users can hover over a variant position on
the sequence to highlight the corresponding position in the
structure and vice versa, which can answer key questions
such as: Is the variant perturbing a metal-interacting site or
a ligand-binding pocket? The selection of a feature or vari-
ant from the sequence viewer shows a tooltip with details
and highlights the corresponding annotation positions on
structure. Besides residue wise investigation, users can se-
lect a full region or functional domain from the sequence
viewer (e.g. the C-terminal helicase domain of DDX3X,
Figure 3) and can visually inspect for the presence of clus-
ters of pathogenic variants. The core capability of MolArt
structure viewer is extended for MISCAST to highlight the
C atoms of the amino acids as spheres. By selecting the
pathogenic and population variants at the same time from
the ‘Variation highlighting’ menu (Figure 3), the user can
compare the spatial distribution of different variant types
in structure. In the case of multiple available protein struc-
tures, users can select a specific structure of interest from
the list of PDB identifiers (sorted alphanumerically, Fig-
ure 3). The structure viewer is expandable to perform in-
depth analysis on the browser. And, importantly, the 3D
structures with residue- and atom-wise (C) annotations are
exportable in PyMOL for advanced analysis, users, for ex-
ample, can introduce new and in-house variants in the ex-
ported structure to investigate it in the context of known
pathogenic and population variants and protein features.
Variant analysis suite: feature table
Annotations of variants and features per amino acid are dis-
played in this page in a dynamic tabular format, where users
can select/deselect a column of interest from the left-side
menu to add to the table. Users can also view a selection of
rows, e.g. only the residues harboring pathogenic or popula-
tion variants. The ‘Download’ button on the top-left corner
of the table will create of a local copy of the table as a tab-
delimited text file.
Variant analysis suite: index table
This page displays the mapping between the genomic in-
dex (format: ‘transcript>chromosome:strand:codon posi-
tions’) and structure index (format: ‘PDB id:chain:residue
position’) of the amino acid residues of proteins. On the
browser end, users can control the number of entries (or
rows) to display in the table. Further, users can view the in-
dex mapping for the full protein or for parts thereof covered
in the structure. The full table is also available to download,
and will assist users to start analyzing a missense variant
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with known genomic position of the variant only, when nec-
essary.
Variant summary report
From the variant summary report track ofMISCAST, users
can obtain a text report for each amino acid residue of pro-
teins summarizing the impact of the substitution of that
residue. The report shows a pathogenic 3D feature index per
residue based on the difference in it’s pathogenic and pop-
ulation variant-associated protein features (identified in an
accompanying and separate study (32)). It is expected that
the residues located in vulnerable 3D sites will have a higher
number of pathogenic variant-associated features. These re-
ports and indices are generated based on the features found
to be enriched in pathogenic and population missense vari-
ants in general (‘All protein classes’) and separately for each
annotated protein class for the query gene.
To illustrate an example, the submission of a gene name
(e.g.DDX3X) on the top of the page will show a drop-down
list of amino acid positions/indices. Selection or typing of
a residue position (e.g. 235) will first list the known variants
affecting that residue, e.g. the substitution of Leucine at po-
sition 235 (L235) to Proline is associated with intellectual
disability. Then the summary report for L235 of DDX3X
encoded nucleic acid binding protein will highlight that it
possesses 6 pathogenic and 1 population variant-associated
features as identified for the nucleic acid binding protein
class in (32). This leads to a pathogenic 3D feature index
value of 6 − 1 = 5 for L235. Users can obtain such sum-
maries for their own set of variants, which importantly, can
also be analyzed with respect to the variants’ protein fea-
tures in structure from the Variant Analysis Suite track.
DISCUSSION AND FUTURE DIRECTION
The number of identified missense variants and challenges
in their interpretation are growing constantly. Currently,
over 75% of all clinically-derived missense variants in Clin-
Var are of uncertain significance (33). To help eliminate
this bottleneck in translational and clinical genetics and
progress towards precision medicine, genomics or pro-
teomics alone are not sufficient, but a bridging platform that
can integrate data from genetics, molecular and structural
biology is needed.MISCASThas been developed to address
precisely this need.
The current version of MISCAST includes variants, pre-
mapped on protein sequences and structures, from some
of the largest catalogs such as gnomAD (5), ClinVar (6),
HGMD (7) though is limited to 1330 disease-associated
genes/proteins (about 6.5% of all human proteins, see Ma-
terials andMethods for selection criteria), and only consid-
ers sequence and structure of canonical protein isoforms. In
contrast, tools such as PhyreRisk (17), VarMap (16) extend
the mapping of variants to alternate isoforms and homol-
ogous structures. Other resources exist that provide a wide
range of informative features which are complementary to
MISCAST: PhyreRisk in association with missense3D (34)
gives the predicted change in structure and free energy
upon mutations, VarSite (15) presents the associated dis-
eases, pathways, tissue specificity and affected organs, mut-
func (35) yields themutation effect on structure stability and
transcription factor binding sites.
Even if limited to a subset of all possible genes in the
current version, the presented web server MISCAST pro-
vides the community with a valuable resource, that is, the
parallel mapping and visualization of pathogenic and pop-
ulationmissense variants on protein sequence and structure
in an interactive web environment. Further integration of
protein feature annotations (e.g. secondary structure type,
residue’s solvent accessible surface area, protein-protein in-
teractions, post-translational modifications, and functional
site/regions) facilitates the quick investigation of the effect
of variants in the context of protein structure and func-
tion, which, otherwise, would require the use of multiple
tools and bioinformatics skills. In addition to the web-based
platform, a unique capability of MISCAST is that the pro-
tein structures fully annotated with variants and features
are freely downloadable for advance analysis in PyMOL,
for example, alignment of the annotated structure with the
homologous structures and explore variants on the aligned
structures, calculation of the distance between mutation lo-
cation and natural ligands.
We believe that MISCAST will serve as a useful resource
for a diverse group of life scientists. For example, geneti-
cists will benefit from the wealth of molecular data by eas-
ily exploring the variants on the structure and get valuable
information (e.g. Is a variant of interest breaking a protein-
stabilizing disulfide bond?). At the same time, structural bi-
ologists will benefit from the genomics data that will allow
them to know, for example, if amutation is present in a large
fraction of the population with a high allele frequency. Such
inclusive analysis using cross-disciplinary data and infor-
mative visuals as available in MISCAST will assist in in-
formed variant interpretation, candidate variant selection
for functional assays, and target selection for drug devel-
opment. In the coming years, we aim to launch subsequent
versions of MISCAST including an advanced set of protein
annotations and increased coverage of the proteome, that
is, all human proteins with available experimental structures
and high-fidelity homologymodels (irrespective of the pres-
ence of a disease-associated variant, which is a filter crite-
rion for the current version).
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